Atlas Trials

MRB 0.3% Serum Effectiveness on 2 Early Clinical Markers of Photoinduced Cutaneous Aging: Actinic Lentigo and Actinic Keratosis

Clinical trial NCT05152407 · UNKNOWN

Trial details

NCT number
NCT05152407
Sponsor
NAOS Institute of Life Science
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Actinic KeratosisActinic Lentigo
Start date
2022-01-01
Primary completion
2023-07-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.